Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 116
Selected: 0
NCT IDTitle
NCT00458679Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells
NCT00709033T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL
NCT01494103Administration of Donor T Cells With the Caspase-9 Suicide Gene
NCT04995003HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
NCT03192462TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer
NCT04401410Anti-SARS Cov-2 T Cell Infusions for COVID 19
NCT00515957Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)
NCT03478215Mesenchymal Stromal Cells in Living Donor Kidney Transplantation
NCT018226523rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN
NCT00040482High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis
NCT01189786Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
NCT00040469Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
NCT00516087LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)
NCT00579111Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)
NCT01247701Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies
NCT01205334Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
NCT03635632C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
NCT04219163Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
NCT04345601Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)
NCT07211737NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma
NCT00840853Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT
NCT02239861TAA-Specific CTLS for Solid Tumors (TACTASOM)
NCT03690011Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells
NCT00586274Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT
NCT02050347Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)
NCT00062868LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma
NCT02379520HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
NCT03768310CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)
NCT01611298Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR
NCT07297160CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors
NCT02065362TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
NCT00056966Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases
NCT02932956Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)
NCT01316146Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)
NCT03596086HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
NCT00048386Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
NCT00578539T-Reg Cell Kinetics, Stem Cell Transplant, REGALE
NCT00058773Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease
NCT00710892CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
NCT00609219T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC
NCT00579137Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders
NCT02276820Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)
NCT00953420Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes
NCT00078520Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
NCT01247688Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies
NCT024397883RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
NCT04715191Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
NCT02442297T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors
NCT01192555Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma
NCT00062855Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma